Corline Biomedical AB OverviewBiotechnology / Healthcare Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and ...

Corline Biomedical isn't a profitable company, so it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option.

If you're interested in Corline Biomedical AB (STO:CLBIO), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your ...

Visit a quote page and your recently viewed tickers will be displayed here.

Corline Biomedical AB (CLBIO) has delivered a 30.37% change over the past year, with a 52-week range between 11.25 and 27.20. What Is the Average Daily Trading Volume of Corline Biomedical AB (CLBIO)?

As of 3:20:18 pm GMT+2. Market open.